Abstract. Chronic inflammation is associated with an infiltration of mononuclear cells, fibroblast proliferation, and elevated levels of prostaglandin (PG) E2. Mononuclear cell conditioned factor (MNCF) medium (5%) stimulated a 100-fold increase in basal human dermal fibroblast PGE2 release over 48 h as compared with fibroblasts that were incubated with control medium (conditioned medium prepared without cells). The MNCF-induced PGE2 production was suppressed by protein synthesis inhibitors. Fibroblasts pretreated with control medium released PGE2 only modestly in response to 1 nM bradykinin for 1 h (basal, 50±7 pg PGE2/,g protein; stimulated, 104±12 pg PGE2flsg protein), whereas cells that had been pretreated with MNCF showed a greatly facilitated bradykinin-induced release of PGE2. (basal, 297±59 pg PGE2/,g protein; stimulated, 866±85 pg PGE2/Ag protein). The exaggerated agonist response is not specific for bradykinin because plateletderived growth factor elicits a similar response. Exogenous arachidonic acid conversion to PGE2 was also facilitated (two-to threefold) by MNCF pretreatment as compared with control. Both the enhanced agoniststimulated and exogenous arachidonic acid-induced PGE2 release from the MNCF pretreated cells were inhibited by actinomyin D or cycloheximide. A kinetic study of microsomal cyclooxygenase prepared from fibroblasts pretreated with MNCF showed a threefold increase in the maximum velocity (Vmax) but the same Michaelis constant (Kin) as control-treated cells. This augmented arachidonic acid metabolism and subsequent enhanced PGE2 production may play an important role